Search

Displaying results 4801 - 4810 of 10000 in total
  1. Drug

    ST266

    go.drugbank.com/drugs/DB18614
    Investigational

    ST266 is an amniotic membrane-derived cellular cytokine solution.

  2. Drug

    MK-4965

    go.drugbank.com/drugs/DB08460
    Experimental

    MK-4965 is an HIV-1 reverse transcriptase inhibitor.

  3. Drug

    Narasin

    go.drugbank.com/drugs/DB11432
    ExperimentalVet approved

    Narasin is an agent with coccidiostatic and antibacterial properties.

    Synonyms: Narasin A
  4. Drug

    TB-402

    go.drugbank.com/drugs/DB06050
    Investigational

    TB-402 is a human antibody binding to Factor VIII, which plays a crucial role in the coagulation of the blood. … It is expected to be developed as a potential treatment to prevent blood clot formation in connection with certain types of heart arrhythmia, such as atrial fibrillation.

  5. Drug

    Zeatin

    go.drugbank.com/drugs/DB11337
    Investigational

    An aminopurine factor in plant extracts that induces cell division. (Grant & Hackh's Chemical Dict, 5th ed)

  6. Drug

    Miridesap

    go.drugbank.com/drugs/DB13087
    Investigational

    Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.

  7. Drug

    Sulfobromophthalein

    go.drugbank.com/drugs/DB13215
    Experimental

    Sulfobromophthalein or otherwise called bromsulphthalein is used as a test of liver function in humans [A174970].

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    MCMV5322A

    go.drugbank.com/drugs/DB17763
    Investigational

    MCMV5322A is an anticytomegalovirus monoclonal IgG1 antibody used in combination with [MCMV3068A] to form RG7667.[A259362]

  9. Drug

    MCMV3068A

    go.drugbank.com/drugs/DB17764
    Investigational

    MCMV3068A is an anticytomegalovirus monoclonal IgG1 antibody used in combination with [MCMV5322A] to form RG7667.[A259362]

  10. Drug

    DS-2325a

    go.drugbank.com/drugs/DB18134
    Investigational

    DS-2325a is an inhibitor of kallikrein 5 under development for the treatment of Netherton Syndrome.